1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Herpes Simplex Keratitis Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Oral Drug 1.2.3 Topical Drug 1.3 Market by Application 1.3.1 Global Herpes Simplex Keratitis Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Herpes Simplex Keratitis Drug Market Perspective (2016-2027) 2.2 Herpes Simplex Keratitis Drug Growth Trends by Regions 2.2.1 Herpes Simplex Keratitis Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Herpes Simplex Keratitis Drug Historic Market Share by Regions (2016-2021) 2.2.3 Herpes Simplex Keratitis Drug Forecasted Market Size by Regions (2022-2027) 2.3 Herpes Simplex Keratitis Drug Industry Dynamic 2.3.1 Herpes Simplex Keratitis Drug Market Trends 2.3.2 Herpes Simplex Keratitis Drug Market Drivers 2.3.3 Herpes Simplex Keratitis Drug Market Challenges 2.3.4 Herpes Simplex Keratitis Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Herpes Simplex Keratitis Drug Players by Revenue 3.1.1 Global Top Herpes Simplex Keratitis Drug Players by Revenue (2016-2021) 3.1.2 Global Herpes Simplex Keratitis Drug Revenue Market Share by Players (2016-2021) 3.2 Global Herpes Simplex Keratitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Herpes Simplex Keratitis Drug Revenue 3.4 Global Herpes Simplex Keratitis Drug Market Concentration Ratio 3.4.1 Global Herpes Simplex Keratitis Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Herpes Simplex Keratitis Drug Revenue in 2020 3.5 Herpes Simplex Keratitis Drug Key Players Head office and Area Served 3.6 Key Players Herpes Simplex Keratitis Drug Product Solution and Service 3.7 Date of Enter into Herpes Simplex Keratitis Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Herpes Simplex Keratitis Drug Breakdown Data by Type 4.1 Global Herpes Simplex Keratitis Drug Historic Market Size by Type (2016-2021) 4.2 Global Herpes Simplex Keratitis Drug Forecasted Market Size by Type (2022-2027) 5 Herpes Simplex Keratitis Drug Breakdown Data by Application 5.1 Global Herpes Simplex Keratitis Drug Historic Market Size by Application (2016-2021) 5.2 Global Herpes Simplex Keratitis Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Herpes Simplex Keratitis Drug Market Size (2016-2027) 6.2 North America Herpes Simplex Keratitis Drug Market Size by Type 6.2.1 North America Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) 6.2.2 North America Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) 6.2.3 North America Herpes Simplex Keratitis Drug Market Size by Type (2016-2027) 6.3 North America Herpes Simplex Keratitis Drug Market Size by Application 6.3.1 North America Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) 6.3.2 North America Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) 6.3.3 North America Herpes Simplex Keratitis Drug Market Size by Application (2016-2027) 6.4 North America Herpes Simplex Keratitis Drug Market Size by Country 6.4.1 North America Herpes Simplex Keratitis Drug Market Size by Country (2016-2021) 6.4.2 North America Herpes Simplex Keratitis Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Herpes Simplex Keratitis Drug Market Size (2016-2027) 7.2 Europe Herpes Simplex Keratitis Drug Market Size by Type 7.2.1 Europe Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) 7.2.2 Europe Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) 7.2.3 Europe Herpes Simplex Keratitis Drug Market Size by Type (2016-2027) 7.3 Europe Herpes Simplex Keratitis Drug Market Size by Application 7.3.1 Europe Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) 7.3.2 Europe Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) 7.3.3 Europe Herpes Simplex Keratitis Drug Market Size by Application (2016-2027) 7.4 Europe Herpes Simplex Keratitis Drug Market Size by Country 7.4.1 Europe Herpes Simplex Keratitis Drug Market Size by Country (2016-2021) 7.4.2 Europe Herpes Simplex Keratitis Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Herpes Simplex Keratitis Drug Market Size (2016-2027) 8.2 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Type 8.2.1 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Application 8.3.1 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Region 8.4.1 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Herpes Simplex Keratitis Drug Market Size (2016-2027) 9.2 Latin America Herpes Simplex Keratitis Drug Market Size by Type 9.2.1 Latin America Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) 9.2.2 Latin America Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) 9.2.3 Latin America Herpes Simplex Keratitis Drug Market Size by Type (2016-2027) 9.3 Latin America Herpes Simplex Keratitis Drug Market Size by Application 9.3.1 Latin America Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) 9.3.2 Latin America Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) 9.3.3 Latin America Herpes Simplex Keratitis Drug Market Size by Application (2016-2027) 9.4 Latin America Herpes Simplex Keratitis Drug Market Size by Country 9.4.1 Latin America Herpes Simplex Keratitis Drug Market Size by Country (2016-2021) 9.4.2 Latin America Herpes Simplex Keratitis Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Herpes Simplex Keratitis Drug Market Size (2016-2027) 10.2 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Type 10.2.1 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Application 10.3.1 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Country 10.4.1 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Details 11.1.2 GlaxoSmithKline Business Overview 11.1.3 GlaxoSmithKline Herpes Simplex Keratitis Drug Introduction 11.1.4 GlaxoSmithKline Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) 11.1.5 GlaxoSmithKline Recent Development 11.2 Vectans Pharma 11.2.1 Vectans Pharma Company Details 11.2.2 Vectans Pharma Business Overview 11.2.3 Vectans Pharma Herpes Simplex Keratitis Drug Introduction 11.2.4 Vectans Pharma Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) 11.2.5 Vectans Pharma Recent Development 11.3 Blistex 11.3.1 Blistex Company Details 11.3.2 Blistex Business Overview 11.3.3 Blistex Herpes Simplex Keratitis Drug Introduction 11.3.4 Blistex Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) 11.3.5 Blistex Recent Development 11.4 Bausch Health 11.4.1 Bausch Health Company Details 11.4.2 Bausch Health Business Overview 11.4.3 Bausch Health Herpes Simplex Keratitis Drug Introduction 11.4.4 Bausch Health Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) 11.4.5 Bausch Health Recent Development 11.5 Aurobindo Pharma 11.5.1 Aurobindo Pharma Company Details 11.5.2 Aurobindo Pharma Business Overview 11.5.3 Aurobindo Pharma Herpes Simplex Keratitis Drug Introduction 11.5.4 Aurobindo Pharma Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) 11.5.5 Aurobindo Pharma Recent Development 11.6 Dr. Reddy’s Laboratories 11.6.1 Dr. Reddy’s Laboratories Company Details 11.6.2 Dr. Reddy’s Laboratories Business Overview 11.6.3 Dr. Reddy’s Laboratories Herpes Simplex Keratitis Drug Introduction 11.6.4 Dr. Reddy’s Laboratories Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) 11.6.5 Dr. Reddy’s Laboratories Recent Development 11.7 Cipla 11.7.1 Cipla Company Details 11.7.2 Cipla Business Overview 11.7.3 Cipla Herpes Simplex Keratitis Drug Introduction 11.7.4 Cipla Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) 11.7.5 Cipla Recent Development 11.8 Jubilant Cadista 11.8.1 Jubilant Cadista Company Details 11.8.2 Jubilant Cadista Business Overview 11.8.3 Jubilant Cadista Herpes Simplex Keratitis Drug Introduction 11.8.4 Jubilant Cadista Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) 11.8.5 Jubilant Cadista Recent Development 11.9 Mylan 11.9.1 Mylan Company Details 11.9.2 Mylan Business Overview 11.9.3 Mylan Herpes Simplex Keratitis Drug Introduction 11.9.4 Mylan Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) 11.9.5 Mylan Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Herpes Simplex Keratitis Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Oral Drug Table 3. Key Players of Topical Drug Table 4. Global Herpes Simplex Keratitis Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Herpes Simplex Keratitis Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Herpes Simplex Keratitis Drug Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Herpes Simplex Keratitis Drug Market Share by Regions (2016-2021) Table 8. Global Herpes Simplex Keratitis Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Herpes Simplex Keratitis Drug Market Share by Regions (2022-2027) Table 10. Herpes Simplex Keratitis Drug Market Trends Table 11. Herpes Simplex Keratitis Drug Market Drivers Table 12. Herpes Simplex Keratitis Drug Market Challenges Table 13. Herpes Simplex Keratitis Drug Market Restraints Table 14. Global Herpes Simplex Keratitis Drug Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Herpes Simplex Keratitis Drug Market Share by Players (2016-2021) Table 16. Global Top Herpes Simplex Keratitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Simplex Keratitis Drug as of 2020) Table 17. Ranking of Global Top Herpes Simplex Keratitis Drug Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Herpes Simplex Keratitis Drug Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Herpes Simplex Keratitis Drug Product Solution and Service Table 21. Date of Enter into Herpes Simplex Keratitis Drug Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) (US$ Million) Table 24. Global Herpes Simplex Keratitis Drug Revenue Market Share by Type (2016-2021) Table 25. Global Herpes Simplex Keratitis Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Herpes Simplex Keratitis Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Herpes Simplex Keratitis Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Herpes Simplex Keratitis Drug Revenue Market Share by Application (2016-2021) Table 29. Global Herpes Simplex Keratitis Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Herpes Simplex Keratitis Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) (US$ Million) Table 32. North America Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) (US$ Million) Table 34. North America Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Herpes Simplex Keratitis Drug Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Herpes Simplex Keratitis Drug Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Herpes Simplex Keratitis Drug Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Herpes Simplex Keratitis Drug Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Herpes Simplex Keratitis Drug Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Herpes Simplex Keratitis Drug Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Herpes Simplex Keratitis Drug Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Herpes Simplex Keratitis Drug Market Size by Country (2022-2027) & (US$ Million) Table 61. GlaxoSmithKline Company Details Table 62. GlaxoSmithKline Business Overview Table 63. GlaxoSmithKline Herpes Simplex Keratitis Drug Product Table 64. GlaxoSmithKline Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million) Table 65. GlaxoSmithKline Recent Development Table 66. Vectans Pharma Company Details Table 67. Vectans Pharma Business Overview Table 68. Vectans Pharma Herpes Simplex Keratitis Drug Product Table 69. Vectans Pharma Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million) Table 70. Vectans Pharma Recent Development Table 71. Blistex Company Details Table 72. Blistex Business Overview Table 73. Blistex Herpes Simplex Keratitis Drug Product Table 74. Blistex Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million) Table 75. Blistex Recent Development Table 76. Bausch Health Company Details Table 77. Bausch Health Business Overview Table 78. Bausch Health Herpes Simplex Keratitis Drug Product Table 79. Bausch Health Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million) Table 80. Bausch Health Recent Development Table 81. Aurobindo Pharma Company Details Table 82. Aurobindo Pharma Business Overview Table 83. Aurobindo Pharma Herpes Simplex Keratitis Drug Product Table 84. Aurobindo Pharma Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million) Table 85. Aurobindo Pharma Recent Development Table 86. Dr. Reddy’s Laboratories Company Details Table 87. Dr. Reddy’s Laboratories Business Overview Table 88. Dr. Reddy’s Laboratories Herpes Simplex Keratitis Drug Product Table 89. Dr. Reddy’s Laboratories Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million) Table 90. Dr. Reddy’s Laboratories Recent Development Table 91. Cipla Company Details Table 92. Cipla Business Overview Table 93. Cipla Herpes Simplex Keratitis Drug Product Table 94. Cipla Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million) Table 95. Cipla Recent Development Table 96. Jubilant Cadista Company Details Table 97. Jubilant Cadista Business Overview Table 98. Jubilant Cadista Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million) Table 99. Jubilant Cadista Recent Development Table 100. Mylan Company Details Table 101. Mylan Business Overview Table 102. Mylan Herpes Simplex Keratitis Drug Product Table 103. Mylan Revenue in Herpes Simplex Keratitis Drug Business (2016-2021) & (US$ Million) Table 104. Mylan Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Herpes Simplex Keratitis Drug Market Share by Type: 2020 VS 2027 Figure 2. Oral Drug Features Figure 3. Topical Drug Features Figure 4. Global Herpes Simplex Keratitis Drug Market Share by Application: 2020 VS 2027 Figure 5. Hospital Pharmacies Case Studies Figure 6. Retail Pharmacies Case Studies Figure 7. Online Pharmacies Case Studies Figure 8. Herpes Simplex Keratitis Drug Report Years Considered Figure 9. Global Herpes Simplex Keratitis Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Herpes Simplex Keratitis Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Herpes Simplex Keratitis Drug Market Share by Regions: 2020 VS 2027 Figure 12. Global Herpes Simplex Keratitis Drug Market Share by Regions (2022-2027) Figure 13. Global Herpes Simplex Keratitis Drug Market Share by Players in 2020 Figure 14. Global Top Herpes Simplex Keratitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Simplex Keratitis Drug as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Herpes Simplex Keratitis Drug Revenue in 2020 Figure 16. Global Herpes Simplex Keratitis Drug Revenue Market Share by Type (2016-2021) Figure 17. Global Herpes Simplex Keratitis Drug Revenue Market Share by Type (2022-2027) Figure 18. North America Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Herpes Simplex Keratitis Drug Market Share by Type (2016-2027) Figure 20. North America Herpes Simplex Keratitis Drug Market Share by Application (2016-2027) Figure 21. North America Herpes Simplex Keratitis Drug Market Share by Country (2016-2027) Figure 22. United States Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Herpes Simplex Keratitis Drug Market Share by Type (2016-2027) Figure 26. Europe Herpes Simplex Keratitis Drug Market Share by Application (2016-2027) Figure 27. Europe Herpes Simplex Keratitis Drug Market Share by Country (2016-2027) Figure 28. Germany Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Herpes Simplex Keratitis Drug Market Share by Type (2016-2027) Figure 36. Asia-Pacific Herpes Simplex Keratitis Drug Market Share by Application (2016-2027) Figure 37. Asia-Pacific Herpes Simplex Keratitis Drug Market Share by Region (2016-2027) Figure 38. China Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Herpes Simplex Keratitis Drug Market Share by Type (2016-2027) Figure 46. Latin America Herpes Simplex Keratitis Drug Market Share by Application (2016-2027) Figure 47. Latin America Herpes Simplex Keratitis Drug Market Share by Country (2016-2027) Figure 48. Mexico Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Herpes Simplex Keratitis Drug Market Share by Type (2016-2027) Figure 52. Middle East & Africa Herpes Simplex Keratitis Drug Market Share by Application (2016-2027) Figure 53. Middle East & Africa Herpes Simplex Keratitis Drug Market Share by Country (2016-2027) Figure 54. Turkey Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Herpes Simplex Keratitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. GlaxoSmithKline Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021) Figure 58. Vectans Pharma Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021) Figure 59. Blistex Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021) Figure 60. Bausch Health Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021) Figure 61. Aurobindo Pharma Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021) Figure 62. Dr. Reddy’s Laboratories Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021) Figure 63. Cipla Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021) Figure 64. Jubilant Cadista Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021) Figure 65. Mylan Revenue Growth Rate in Herpes Simplex Keratitis Drug Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

GlaxoSmithKline Vectans Pharma Blistex Bausch Health Aurobindo Pharma Dr. Reddy’s Laboratories Cipla Jubilant Cadista Mylan